|
Mr Williamson is the founder of LaSalle Venture Advisors a consultancy serving venture-backed and public life science companies and their investors on strategic and operational issues. He currently serves as a non-executive director of Pharmasset Inc. (NASDAQ:VRUS) an anti-viral therapeutics company. Prior to founding LaSalle Venture Advisors Mr Williamson served as President and CEO of Arriva Pharmaceuticals Inc. and helped the company raise $27 million in venture capital. Previously Mr Williamson was President and Chief Operating Officer of EOS Biotechnology Inc. (now known as PDL BioPharma (NASDAQ:PDLI)). Prior to this Mr Williamson was President and Chief Operating Officer of DoubleTwist Inc. (formerly Pangea Systems) a genomics start-up. Mr Williamson began his career at The Boston Consulting Group Inc. a global business consulting firm where he was named a Partner and led the firm's west coast health care practice. Mr Williamson received a MBA from the Stanford Graduate School of business in Stanford CA . He obtained a B.A. in Economics from Pomona College in Claremont CA. | 